Preclinical data have demonstrated that the FGF/FGFR1 axis is a key mediator of angiogenesis [10,11] and PCa dissemination [10,11], whereas targeting this pathway inhibited both tumor growth and blood vessel formation [12]. This evidence concerns the gene FGFR1 and posterior cortical atrophy.